Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morse CyberKnife Centers is a healthcare organization specializing in advanced robotic radiosurgery, with facilities located across Florida, including its flagship center in Miami. Managed by Morse LLC and founded by Dr. James G. Schwade, the organization utilizes the CyberKnife System to deliver non-invasive, high-precision radiation therapy for a wide range of cancerous and benign conditions. The centers treat tumors in the brain, spine, lung, prostate, and liver, offering a non-surgical alternative that minimizes damage to healthy tissue and typically requires only one to five sessions. As an open-staff facility, Morse CyberKnife Centers collaborate with a multidisciplinary team of radiation oncologists and surgeons to provide personalized treatment plans. The organization is recognized as a pioneer in the field, having launched the first CyberKnife program in the Southeastern United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Morse CyberKnife Centers.